Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Medicated Skin Care in

Dermatologicals in Brazil

Oct 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Dermatologicals negatively affected by not being considered as an essential item

The worsening economic situation as a consequence of the measures implemented to contain the spread of the COVID-19 pandemic has seen many Brazilians lose their jobs and significantly affected the disposable incomes of local consumers. This meant that, following the recent economic crises in the country, local consumers were once again having to carefully consider their expenditure, with many focusing on only buying essential items and brands that offered a best cost-benefit ratio.

Stay-at-home recommendations affecting sales of specific categories

The policy adopted in Brazil by many states and cities, recommending that people stay at home where possible, meant that many children were spending much more time at home than they used to before the COVID-19 pandemic arrived in the country. This saw children’s interactions with each other drastically reduced, helping to limit the spread of common diseases among them.

Johnson & Johnson remains the leader in dermatologicals

Johnson & Johnson continues to lead dermatologicals in Brazil, thanks to its strong brand portfolio under nappy (diaper) rash treatments. The company continues to invest heavily in its brands and recently implemented a significant change under its Hipoglós line, the leading brand in the overall category.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Brazil with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Brazil, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Brazil market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in Brazil?
What are the major brands in Brazil?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in Brazil - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Dermatologicals negatively affected by not being considered as an essential item

Stay-at-home recommendations affecting sales of specific categories

Johnson & Johnson remains the leader in dermatologicals

RECOVERY AND OPPORTUNITIES

Dermatologicals sales will return to “normal” levels in the post-pandemic period

Trading down could continue to affect sales in the short term

Hypera, now in second place, expected to continue increasing its presence in dermatologicals

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2015-2020
Table 2 Sales of Dermatologicals by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals: % Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: % Value 2017-2020
Table 5 Forecast Sales of Dermatologicals by Category: Value 2020-2025
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025

Consumer Health in Brazil - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Megatrends

Country Report

Dermatologicals in Brazil

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Dermatologicals negatively affected by not being considered as an essential item

Stay-at-home recommendations affecting sales of specific categories

Johnson & Johnson remains the leader in dermatologicals

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in Brazil - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Dermatologicals negatively affected by not being considered as an essential item

Stay-at-home recommendations affecting sales of specific categories

Johnson & Johnson remains the leader in dermatologicals

RECOVERY AND OPPORTUNITIES

Dermatologicals sales will return to “normal” levels in the post-pandemic period

Trading down could continue to affect sales in the short term

Hypera, now in second place, expected to continue increasing its presence in dermatologicals

CATEGORY DATA

Consumer Health in Brazil - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports